Intuit, Gusto both tout Claude integrations; Oracle premiers Fusion Agentic Applications; Suralink launches Financial ...
Developing new drugs is not for the faint-hearted. “It’s a pretty perilous journey,” says Paul Nioi, vice-president of discovery and translational research at Alnylam Pharmaceuticals. “It’s expensive ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果